6 0

Stefanie Joho, 27, in Penn Valley, Pa., last spring, was treated with Merck's Keytruda for advanced colon cancer. A new study shows that the immunotherapy drug, when combined with chemotherapy, also prolongs survival in patients with advanced lung cancer. (Photo by Michelle Gustafson for The Washington Post). Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study that is expected to change the way such patients are treated. The report was one of several highly anticipated studies on immunotherapy and lung cancer presented Monday at the annual meeting... Full story

16 April